The company's patented enzyme works with nucleoside prodrugs to generate active metabolites with high levels of anti-tumor activity, and their gene-therapy technology aims to program solid tumors to generate their own chemotherapy and self-destruct, using nucleoside pro-drugs that destroy tumor cells in a confined environment.